Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067507 · ClinicalTrials.gov registry record · NA
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 53,414
- Enrollment target
NCT02067507: Completed NA study, sponsored by University of California, Los Angeles.
NCT02067507 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 53,414 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3707% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02067507, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 53,414 participants
- Enrollment target
Study Summary
The primary aim of the project is to increase human papillomavirus (HPV) vaccine receipt rates among low-income, ethnic minority adolescents (girls and boys 11-17 years of age) in Los Angeles County. We will accomplish this goal by implementing and rigorously evaluating interventions in multiple venues that serve our target population, including the Los Angeles County Department of Public Health (LACDPH) and two large Federally Qualified Health Centers (FQHCs). Our hypotheses are: Primary hypothesis: 1. The intervention group will have a higher rate of HPV vaccine initiation at follow-up compared to the control group. Secondary hypothesis: 2. The intervention group will have higher vaccine completion rates (3 doses) at follow-up compared to the control group.
Primary Outcome
The receipt of one or more doses of the HPV vaccine
Interventions
- BEHAVIORAL Tailored education and referral
- BEHAVIORAL Staff training and patient reminders
- BEHAVIORAL Clinic-level reminder systems
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53,414 participants |
| Start Date | 2012-06 |
| Est. Completion | 2019-10 |
| Phase | NA |
What the finished NCT02067507 record still lists
NCT02067507 is an interventional study that assigns participants to a tested intervention. Its 53,414 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3707% higher).
The record links to 0 conditions, and to 3 interventions - of which Tailored education and referral is the first listed.
NCT02067507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02067507 about?
NCT02067507 is a clinical study titled "Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County". The primary aim of the project is to increase human papillomavirus (HPV) vaccine receipt rates among low-income, ethnic minority adolescents (girls and boys 11-17 years of age) in Los Angeles County. We will accomplish this goal by implementing and rigorously evaluating interventions in multiple ven...
What is the current status of trial NCT02067507?
This trial is currently completed. It is a NA study. The enrollment target is 53,414 participants. The study started on 2012-06. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02067507?
The interventions under investigation include: Tailored education and referral (BEHAVIORAL), Staff training and patient reminders (BEHAVIORAL), Clinic-level reminder systems (BEHAVIORAL).
Who is sponsoring clinical trial NCT02067507?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02067507's enrollment target sits among peer trials
53,414 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07224243 · 54,000 participants · NA
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia